Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Total Debt (2021 - 2025)

Historic Total Debt for Legend Biotech (LEGN) over the last 5 years, with Q3 2025 value amounting to $142.9 million.

  • Legend Biotech's Total Debt fell 5183.35% to $142.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $142.9 million, marking a year-over-year decrease of 5183.35%. This contributed to the annual value of $281.3 million for FY2023, which is 781.66% up from last year.
  • According to the latest figures from Q3 2025, Legend Biotech's Total Debt is $142.9 million, which was down 5183.35% from $310.3 million recorded in Q2 2025.
  • In the past 5 years, Legend Biotech's Total Debt ranged from a high of $310.3 million in Q2 2025 and a low of $17310.0 during Q2 2021
  • Its 5-year average for Total Debt is $220.4 million, with a median of $270.6 million in 2023.
  • Per our database at Business Quant, Legend Biotech's Total Debt soared by 11660.94% in 2022 and then plummeted by 5183.35% in 2025.
  • Over the past 5 years, Legend Biotech's Total Debt (Quarter) stood at $120.5 million in 2021, then soared by 116.61% to $260.9 million in 2022, then grew by 7.82% to $281.3 million in 2023, then increased by 5.44% to $296.6 million in 2024, then tumbled by 51.83% to $142.9 million in 2025.
  • Its Total Debt stands at $142.9 million for Q3 2025, versus $310.3 million for Q2 2025 and $305.7 million for Q1 2025.